Clover Health Investments Corp’s recent filing unveils that its Director Garipalli Vivek acquired Company’s shares for reported $1.0 million on Aug 09 ’24. In the deal valued at $1.88 per share,531,700 shares were bought. As a result of this transaction, Garipalli Vivek now holds 1,409,267 shares worth roughly $4.52 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Garipalli Vivek bought 877,567 shares, generating $1,000,426 in total proceeds. Upon buying the shares at $1.14, the Director now owns 877,567 shares.
Before that, Loengard Anna U bought 17,085 shares. Clover Health Investments Corp shares valued at $16,372 were divested by the Director at a price of $0.96 per share. As a result of the transaction, Loengard Anna U now holds 15,600 shares, worth roughly $50076.0.
Craig Hallum initiated its Clover Health Investments Corp [CLOV] rating to a Buy in a research note published on December 17, 2024; the price target was $6. A number of analysts have revised their coverage, including UBS’s analysts, who began to cover the stock in early October with a ‘”a Neutral”‘ rating. Cowen also remained covering CLOV and has increased its forecast on February 02, 2022 with a “Market perform” recommendation from previously “an Underperform” rating. Canaccord Genuity started covering the stock on February 02, 2022. It rated CLOV as “a Buy”.
Price Performance Review of CLOV
On Tuesday, Clover Health Investments Corp [NASDAQ:CLOV] saw its stock jump 2.88% to $3.21. Over the last five days, the stock has gained 1.26%. Clover Health Investments Corp shares have risen nearly 237.15% since the year began. Nevertheless, the stocks have risen 225.76% over the past one year. While a 52-week high of $4.71 was reached on 10/17/24, a 52-week low of $0.61 was recorded on 04/22/24. SMA at 50 days reached $3.63, while 200 days put it at $2.09.
Levels Of Support And Resistance For CLOV Stock
The 24-hour chart illustrates a support level at 3.12, which if violated will result in even more drops to 3.03. On the upside, there is a resistance level at 3.28. A further resistance level may holdings at 3.36. The Relative Strength Index (RSI) on the 14-day chart is 43.35, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.14, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 57.38%. Stochastics %K at 32.24% indicates the stock is a holding.
How much short interest is there in Clover Health Investments Corp?
A steep rise in short interest was recorded in Clover Health Investments Corp stocks on 2024-11-29, dropping by -3.05 million shares to a total of 15.28 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 18.33 million shares. There was a decline of -19.98%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on January 19, 2022 when SVB Leerink began covering the stock and recommended ‘”a Mkt perform”‘ rating along with a $3 price target.
